Cardiovascular Research
Amino-terminal probrain natriuretic peptide marks patients with highest sudden death risk
Published in Blood Weekly, December 8th, 2005
"Even in high-risk population groups, not all patients have the same risk of sudden cardiac death (SCD)," cardiologists in Greece explained.
"Given the emerging data about the amino-terminal fragment of the brain natriuretic peptide prohormone (NT-proBNP) value in heart failure," E.G. Manios and colleagues at Heraklion University Hospital conducted a "prospective study" to "evaluate the importance of NT-proBNP levels in predicting the occurrence of malignant arrhythmias in patients with ischemic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-12-08)
More Articles from Blood Weekly
- Blood Safety
Empirical model investigates the determinants of a safe and sufficient blood supply - Bone Fracture
Osteoblastic cells mobilized and recruited from remote bone marrow sites for fracture healing - Stem Cell Research
Increased circulating endothelial progenitor cells associated with survival in acute lung injury - Surgery
Blood transfusions performed after musculoskeletal tumor surgery - Tissue Engineering
Collagen-modified PLGA scaffold developed for tissue engineering of the esophagus - Acute Myeloid Leukemia
Clofarabine's duration of response improves outcome for elderly AML patients - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
